Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia

Blood

Volumn 97, Issue 2, 2001, Pages 393-398

  Kearns, Pamela R ^b   Pieters, Rob ^b   Rottier, M M Antoinette ^b   Pearson, Andrew D J ^b   Hall, Andrew G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GLUTATHIONE; IFOSFAMIDE; MERCAPTOPURINE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CANCER RECURRENCE; CELL LEVEL; CELL LINEAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; LEUKOCYTE COUNT; MALE; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SURVIVAL RATE;

EID: 0035863889     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.2.393     Document Type: Article

References (47)

1. The United Kingdom Medical Research Council trials for the treatment of childhood acute lymphoblastic leukaemia
2. Treatment of childhood acute lymphoblastic leukaemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01
3. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: Results and conclusions of the multicenter trial ALL-BFM 86
4. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: Cranial radiation requires an accomplice
5. Pubertal growth in young adult survivors of childhood leukemia
6. Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia
7. Anthracyclines: Cardiotoxicity and its prevention
8. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer
9. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: Differences in outcome are poorly explained by the most significant prognostic variables
10. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition
11. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts
12. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
13. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis
14. Redox regulation of apoptosis: Impact of thiol oxidation status on mitochondrial function
15. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody
16. A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes
17. Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs
18. Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukemia
19. Intracellular glutathione content in leukemias
20. Glutathione in childhood acute leukaemias
21. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions
22. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione
23. Microtitre plate technique for the measurement of glutathione in fresh and cryopreserved lymphoblasts using the enzyme recycling method
24. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia
25. Drug combination testing in acute lymphoblastic leukemia using the MTT assay
26. Increased glutathione in chronic lymphocytic leukemia lymphocytes
27. Glutathione and related enzymes in multidrug resistance
28. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione
29. A study of the mechanism of resistance to Adriamycin in vivo: Glutathione metabolism, P-glycoprotein expression, and drug transport
30. Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: Clinical and biochemical results
31. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: An attempt at modulation of glutathione
32. Effect of ifosfamide on intracellular glutathione levels in peripheral blood lymphocytes and its correlation with therapeutic response in patients with advanced ovarian cancer
33. Depletion of tumour glutathione in vivo by buthionine sulphoximine: Modulation by the rate of cellular proliferation and inhibition of cancer growth
34. Proliferative capacity of human peripheral blood lymphocytes sorted on the basis of glutathione content
35. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function
36. Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia
37. Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood
38. Relationship of pretreatment lymphoblast proliferative activity and prognosis in 97 children with acute lymphoblastic leukaemia
39. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia
40. Determination of glutathione in lymphocytes and possible association of redox state and proliferative capacity of lymphocytes
41. Functions of glutathione and glutathione disulfide in immunology and immunopathology
42. Endogenously generated active oxygen species and cellular glutathione levels in relation to BHK-21 cell proliferation
43. Non-oxidative loss of glutathione in apoptosis via GSH extrusion
44. Redox regulation of Fos and Jun DNA binding activity in vitro
45. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
46. Protective effect of N-acetylcysteine in tumour necrosis factor-alpha-induced apoptosis in U937 cells: The role of mitochondria
47. Antileukemic action of buthionine sulfoximine: Evidence for an intrinsic death mechanism based on oxidative stress